EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL • US28176E1082
70.94 EUR
+1.09 (+1.56%)
Last: Feb 25, 2026, 07:00 PM
EWL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, EWL is valued expensive at the moment. These ratings could make EWL a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- EWL had positive earnings in the past year.
- In the past year EWL had a positive cash flow from operations.
- In the past 5 years EWL has always been profitable.
- EWL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 10.31%, EWL belongs to the top of the industry, outperforming 90.77% of the companies in the same industry.
- With a decent Return On Equity value of 13.40%, EWL is doing good in the industry, outperforming 78.46% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 12.09%, EWL belongs to the best of the industry, outperforming 87.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.09% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EWL has a better Profit Margin (23.25%) than 93.85% of its industry peers.
- In the last couple of years the Profit Margin of EWL has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 27.73%, EWL belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
- In the last couple of years the Operating Margin of EWL has declined.
- With an excellent Gross Margin value of 78.19%, EWL belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
- EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
- EWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- EWL has an Altman-Z score of 12.26. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of EWL (12.26) is better than 93.85% of its industry peers.
- The Debt to FCF ratio of EWL is 0.75, which is an excellent value as it means it would take EWL, only 0.75 years of fcf income to pay off all of its debts.
- EWL's Debt to FCF ratio of 0.75 is amongst the best of the industry. EWL outperforms 90.77% of its industry peers.
- A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
- With an excellent Debt to Equity ratio value of 0.06, EWL belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.26 |
ROIC/WACC1.22
WACC9.91%
2.3 Liquidity
- EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
- EWL's Current ratio of 4.00 is amongst the best of the industry. EWL outperforms 92.31% of its industry peers.
- A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.29, EWL belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
- EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.29%.
- EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.67% yearly.
- Looking at the last year, EWL shows a quite strong growth in Revenue. The Revenue has grown by 10.86% in the last year.
- EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
3.2 Future
- The Earnings Per Share is expected to grow by 12.79% on average over the next years. This is quite good.
- Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 9.72% on average per year.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 32.69, EWL can be considered very expensive at the moment.
- EWL's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.21, EWL is valued a bit more expensive.
- A Price/Forward Earnings ratio of 28.12 indicates a quite expensive valuation of EWL.
- 61.54% of the companies in the same industry are cheaper than EWL, based on the Price/Forward Earnings ratio.
- EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.69 | ||
| Fwd PE | 28.12 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EWL indicates a slightly more expensive valuation: EWL is more expensive than 66.15% of the companies listed in the same industry.
- EWL's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.67 | ||
| EV/EBITDA | 24.67 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of EWL may justify a higher PE ratio.
- A more expensive valuation may be justified as EWL's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)2.03
PEG (5Y)4.9
EPS Next 2Y13.34%
EPS Next 3Y13.01%
5. Dividend
5.1 Amount
- EWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EWL (2/25/2026, 7:00:00 PM)
70.94
+1.09 (+1.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)04-21 2026-04-21/amc
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap41.17B
Revenue(TTM)6.07B
Net Income(TTM)1.37B
Analysts79.53
Price Target82.86 (16.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)-2.06%
PT rev (3m)1.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.06%
EPS NY rev (1m)0.43%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.69 | ||
| Fwd PE | 28.12 | ||
| P/S | 8.24 | ||
| P/FCF | 60.67 | ||
| P/OCF | 47.71 | ||
| P/B | 4.75 | ||
| P/tB | 6.64 | ||
| EV/EBITDA | 24.67 |
EPS(TTM)2.17
EY3.06%
EPS(NY)2.52
Fwd EY3.56%
FCF(TTM)1.17
FCFY1.65%
OCF(TTM)1.49
OCFY2.1%
SpS8.6
BVpS14.92
TBVpS10.68
PEG (NY)2.03
PEG (5Y)4.9
Graham Number26.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.09% | ||
| ROICexc | 18.01% | ||
| ROICexgc | 28.58% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.26 |
F-Score5
WACC9.91%
ROIC/WACC1.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year24.3%
EBIT Next 3Y14.62%
EBIT Next 5Y14.72%
FCF growth 1Y67.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.09%
OCF growth 3YN/A
OCF growth 5YN/A
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.
What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.69 and the Price/Book (PB) ratio is 4.75.